Kirill G. Shostka

Kirill G. Shostka

Auto-generated profile, based on publicly available information

Kirill G. Shostka

Saint Petersburg State University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
MCM. A. Chernykh
M. A. Chernykh
ABA. M. Belousov
A. M. Belousov
KSK. G. Shostka
K. G. Shostka
The article discusses the problem of colonic anastomotic leakage in patients who underwent resection for colorectal cancer. We describe risk factors for colonic anastomotic leakage and diagnostic approaches. Particular attention is given to noninvasive early diagnosis of anastomotic leakage using laboratory tests with specific biochemical markers.

7 March 2024 in Voprosy onkologii
Verified
Journal Article
Open access
МКМария Олеговна Карпенко
Мария Олеговна Карпенко
КШКирилл Георгиевич Шостка
Кирилл Георгиевич Шостка
ЕЗЕвгений Владимирович Загайнов
Евгений Владимирович Загайнов
АШАлексей Владимирович Шиляев
Алексей Владимирович Шиляев
ИКИлья Владимирович Калинин
Илья Владимирович Калинин
Introduction. The article presents the evaluation of perioperative results of pelvic exenteration (PE) in patients with primary locally advanced and locally recurrent colorectal cancer. Materials and Methods. From 2005 to 2022, 206 operations were performed in Leningrad Regional Clinical Oncological Dispensary named after L.D. Roman. The mean age of the patients was 61 years, with 168 (82 %) females and 38 (18 %) males. The following types of PE were performed: supralevator total exenteration with anastomosis — 28 (13.6 %), supralevator total exenteration without anastomosis — 14 (6.8 %), infralevator total exenteration — 20 (9.7 %), anterior exenteration with vaginal resection — 1 (0.5 %), supralevator posterior exenteration with anastomosis — 65 (31.6 %), supralevator obstructive posterior exenteration — 48 (23.3 %), infralevator posterior exenteration — 30 (14.5 %). Results. 106 (51.5 %) patients developed postoperative complications. The mortality rate was 8.7 %. Overall survival (OS) in the R0 resection subgroup was the following: 3-year OS was 56.5 % (95 % CI 48.3-66.2) and 5-year OS was 47.3 % (95 % CI 38.5-58.1). There was a statistically significant difference in the 5-year OS between patients with R0 or R1/R2 resection (p = 0.01). Median survival was 26 months for R0 group, and 11 months for R1/R2 groups. Conclusion. The most important prognostic factor for assessing OS is the achievement of R0 resection. The nature of the tumor did not affect the long-term survival. PE should be performed in centers with appropriate experience. Введение. Представлена оценка периоперационных и отдаленных результатов эвисцераций органов малого таза у пациентов с первичным местно-распространенным и местно-рецидивирующим колоректальным раком. Материалы и методы. В период с 2005 по 2022 гг. в ГБУЗ ЛОКОД им. Л.Д. Романа выполнено 206 операций. Средний возраст пациентов составил 61 год, женщин — 168 (82 %) и мужчин — 38 (18 %). Характер и вид выполненных эвисцераций: тотальная супралеваторная с анастомозом — 28 (13,6 %), тотальная супралеваторная без анастомоза — 14 (6,8 %), тотальная инфралеваторная — 20 (9,7 %), передняя эвисцерация с резекцией влагалища — 1 (0,5 %), задняя надлеваторная эвисцерация с анастомозом — 65 (31,6 %), обструктивная задняя надлеваторная эвисцерация — 48 (23,3 %), задняя инфралеваторная эвисцерация — 30 (14,5 %). Результаты. Послеоперационные осложнения развились у 106 (51,5 %) пациентов. Летальность составила 8,7 %. Выживаемость в подгруппе R0 резекций составила: 3-х летняя и 5-ти летняя — 56,5 % (95 % ДИ 48,3–66,2) и 47,3 % (95 % ДИ 38,5–58,1) соответственно. Наблюдалась статистически значимая разница в общей 5-летней выживаемости между пациентами с R0 и R1/R2 резекцией (р = 0,01). Медиана выживаемости составила для пациентов из группы резекции R0 — 26 месяцев, в группе R1/R2 резекции — 11 месяцев. Выводы. Наиболее важным прогностическим фактором для оценки выживаемости является достижение резекции в объеме R0. Характер опухоли на результаты отдаленной выживаемости не повлиял. Выполнение эвисцераций органов малого таза целесообразно в высокопотоковых центрах.

9 September 2025 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
MCM.A. Chernykh
M.A. Chernykh
ABA.M. Belousov
A.M. Belousov
KSK.G. Shostka
K.G. Shostka
Objective. To evaluate diagnostic significance of IL-6 compared to CRP for early detection of anastomotic leakage after colon resection for colorectal cancer. Material and methods. The study included 277 patients who underwent total resection for colorectal cancer. Patients were retrospectively divided into three groups: without complications (n=227), with anastomotic leakage (n=30), and other postoperative complications (n=20). CRP and IL-6 were measured daily for 5 postoperative days. Dynamics of markers and their diagnostic significance were estimated using ROC analysis. Results. Serum IL-6 in patients with anastomotic leakage reached significant values after 2 postoperative days (AUC=0.872, cut-off=51.2 pg/ml, sensitivity 79.3%, specificity 89.1%) and maximum after 3 days (AUC=0.949, cut-off=66.4 pg/ml, sensitivity 80.0%, specificity 96.8%). CRP demonstrated diagnostically significant values after 3—4 days (AUC=0.875 after 3 days and 0.926 after 4 days). Dynamics of IL-6 after intervention for anastomotic leakage indicated advisability of this marker to assess the quality of abdominal debridement. Conclusion. IL-6 is a perspective early marker of anastomotic leakage with high sensitivity and specificity after 2 days. This significantly reduces the diagnostic time compared to CRP. IL-6 can optimize postoperative management of patients contributing to early detection of complications and timely intervention.

19 June 2025 in Surgery and Oncology
Verified
Journal Article
Open access
PDF file
ACA. N. Cheglakov
A. N. Cheglakov
KSK. G. Shostka
K. G. Shostka
NMN. V. Mankevich
N. V. Mankevich
ABA. M. Belousov
A. M. Belousov
Introduction. Pelvic side wall could be involved by tumor or desmoplastic reaction in patients with gynaecological pelvic malignancies and rectal cancer. Up until recently surgery was considered to have no prospects due to high frequency of palliative procedures and low survival rate.Aim. To conduct a retrospective analysis of short- and long-term results in patients after laterally extended endopelvic resection.Materials and methods. This study included consecutive patients between 2013 and 2023, who undergone laterally extended endopelvic resection at the Leningrad Regional Oncology Center named by L.D. Roman. Principal data were collected and classified. G. Vizzielli and R. Naik classification formed the grounds for surgery type selection. Procedure was considered to be radical with no signs of macro- and microscopic tumor presence in surgical margins.Results. Over the 2013 to 2023 period 54 laterally extended endopelvic resections were performed. Of these, 50 (92.6 %) were woman and 4 (7.4 %) men. An R0 resection was performed in 44 (81 %) of 54 cases, postoperative morbidity was 67 % with 5,6 % mortality, and 5-year overall survival of 23 %. 5-year overall survival was reached only in patients with colorectal cancer (44 %) and uterus tumors (40 %). In case of palliative procedures (R1/R2 resection) overall survival was less than 3 years.Conclusion. Clear resection margin was considered to be the crucial prognostic factor. An improvement of surgical techniques, an exploration of pelvic side wall structures, and sensible patient selection could improve short- and long-term outcomes in this complex group of patients.

30 November 2024 in Surgery and Oncology
Verified
Journal Article
Open access
PDF file
ACA. N. Cheglakov
A. N. Cheglakov
KSK. G. Shostka
K. G. Shostka
NMN. V. Mankevich
N. V. Mankevich
ABA. M. Belousov
A. M. Belousov
Patients with tumor involvement of lateral pelvic sidewall represent a peculiar category and were not assessed as the candidates for curative surgery up until recent years. The aim of the current review of literature is to display the working results of the most experienced surgical oncologists in pelvic surgery. We have analyzed issue-related articles, which were published from 1967 till 2023, considering the free margin status as a key prognostic factor. It is elucidated that R0 resection could be achieved in more than a half cases, 5 year overall survival ran up to 50 %, and postoperative mortality was less than 7 %. The majority of authors described high morbidity though (up to 82 %). Exenteration with laterally extended endopelvic resection could improve overall survival rate in patients with locally advanced pelvic malignancies granting sensible patient selection in expert medical care unit.

20 September 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
NBNikita Burlov
Nikita Burlov
GKG. N. Khrykov
G. N. Khrykov
EBE. A. Burlova
E. A. Burlova
KSK. G. Shostka
K. G. Shostka
Aim. To evaluate the effectiveness of the PREPARE score in predicting severe complications after pancreatic surgery.Materials and Methods. The case-control study included patients operated on the pancreas. Grade ≥III Clavien– Dindo complications were designated as “severe”. Patients were divided into two groups: “0–II degree” (control) and “III–V degree” (case). For all patients, scores were calculated, and risk categories were determined according to the PREPARE score.Results. The study included 151 patients: “0–II degree” – 102 (68%) observations, “III–V degree” – 49 (32%). ROC analysis was used for the scores (AUC = 0.616; 95% CI 0.527–0.706; p = 0.014) and for the risk categories (AUC = 0.555; 95% CI 0.463–0.648; p = 0.241) of the PREPARE score.Conclusion. The obtained data do not currently enable us to recommend the PREPARE score for predicting complications of pancreatic surgery.